February 8, 2023
PAR-21-173, "Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
National Institute of Mental Health (NIMH)
The purpose of this Notice is to inform potential applicants of the National Institute of Mental Health (NIMH) participation, effective immediately, in PAR-21-173, "Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
The following text has been added to reflect NIMH's participation in this FOA:
Part 1. Overview Information
Components of Participating Organizations
National Institute of Mental Health (NIMH)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.242
Part 2. Section I. Funding Opportunity Description
NIMH Area of Interest: The mission of the NIMH is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure. NIMH supports research on topics that include basic neuroscience and behavioral science, and translational application of brain and behavior relationships in healthy and diseased states. Applications considered for funding by the NIMH must fall within the areas of priority detailed in the NIMH Strategic Plan and the NIMH Strategic Research Priorities. It is recommended that investigators contact NIMH Scientific/Research staff well in advance of submitting applications to discuss the match to NIMH priorities.?
Part 2. Section VII. Agency Contacts
Scientific/Research Contact(s)
Brittany Haynes, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-496-2767
Email: [email protected]
Financial/Grants Management Contact(s)
Rita Sisco
National Institute of Mental Health (NIMH)
Telephone: 301-443-2805
Email: [email protected]
Brittany Haynes, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-496-2767
Email: [email protected]